GLP-1 receptor agonists reduce apnea-hypopnea index by 15.28 events per hour in obstructive sleep apnea
GLP-1 receptor agonists show promise for obstructive sleep apnea
This network meta-analysis of 15 studies involving 1,877 participants found that GLP-1 receptor agonists significantly reduced the apnea-hyp…
New data suggests GLP-1 receptor agonists may reduce sleep apnea symptoms and improve oxygen levels in overweight or obese patients.
TyG-derived indices like TyG-WC and CTI show stronger cardiovascular risk associations than the TyG index
New ways to measure heart health risks using blood markers
This meta-analysis of 80 observational studies evaluates TyG-derived indices in populations with cardiovascular-kidney-metabolic syndrome. T…
Combining triglyceride and glucose levels into specific formulas can better predict the risk of heart disease and death in high-risk patient…
Intrauterine PRP or PRGF infusion increases endometrial thickness but clinical pregnancy results remain fragile
Platelet Rich Plasma May Help Thin Endometrium During Fertility Treatment
This systematic review and meta-analysis examined the impact of intrauterine platelet-rich plasma (PRP) or plasma rich in growth factors (PR…
New research suggests that injecting platelet-rich plasma may increase endometrial thickness for women with thin linings during fertility tr…
Breakfast Macronutrient Adjustments Improve Glycemic Control in Diabetes
Specific Breakfast Macronutrients Help Control Blood Sugar in Diabetes
Meta-analysis of 25 RCTs finds tailored breakfast macronutrients reduce postprandial glucose and HbA1c in diabetes.
Changing the balance of fats, proteins, and fibers at breakfast can help manage blood sugar levels for people living with diabetes.
Tirzepatide reduces hypertension risk but increases hypotension risk compared to semaglutide in T2DM and obesity
Tirzepatide shows lower risk of high blood pressure than semaglutide
This meta-analysis of 47,332 patients with Type 2 Diabetes Mellitus or obesity compared tirzepatide and semaglutide regarding blood pressure…
New data compares how two popular weight and diabetes medications affect blood pressure, showing different risks for each treatment.
Meta-analysis Evaluating Cardiovascular Mortality Risk in Patients with Overt and Subclinical Hypothyroidism
Hypothyroidism is linked to higher risk of heart-related deaths
A meta-analysis of 9,662 patients reveals that while hypothyroidism shows no clear link to incident CV events, it significantly increases mo…
A large review of data suggests that people with hypothyroidism may face a significantly higher risk of dying from heart conditions.
Evaluation of Once Weekly Subcutaneous Zenagamtide for Management of Type 2 Diabetes
New weekly injection shows promise for managing Type 2 Diabetes
Zenagamtide, a dual GLP-1 and amylin agonist, demonstrated significant HbA1c reductions in patients with type 2 diabetes over 36 weeks.
A new once-weekly injection showed significant reductions in blood sugar levels for adults living with Type 2 diabetes during a recent clini…
Obesity increases colorectal cancer risk while normal weight is associated with lower risk
Higher body mass index linked to earlier colorectal cancer risk
This meta-analysis of multi-country population data examines the association between BMI categories and colorectal cancer (CRC) risk. Findin…
Research shows that people with obesity may face a higher risk of colorectal cancer and could need earlier screening than those with normal …
FDA Approves Synjardy XR (empagliflozin/metformin HCl ER) for Type 2 Diabetes
FDA approves new once-daily pill for adults with type 2 diabetes.
The FDA approved Synjardy XR (empagliflozin and metformin HCl extended-release) as an adjunct to diet and exercise to improve glycemic contr…
The FDA approved Synjardy XR, a once-daily pill combining empagliflozin and metformin, to improve blood sugar control in adults with type 2 …
Poor glycemic control in Type 2 Diabetes is associated with lower FEV1 and FVC volumes
Poor blood sugar control linked to lower lung function in diabetes
This meta-analysis of observational studies indicates that patients with Type 2 Diabetes Mellitus and poor HbA1c levels have lower absolute …
People with type 2 diabetes and poor blood sugar control may experience lower lung volumes compared to those with well managed levels.
FDA Approves Segluromet (ertugliflozin/metformin) for Type 2 Diabetes
FDA approves new combination pill for type 2 diabetes
The FDA approved Segluromet (ertugliflozin/metformin) as an adjunct to diet and exercise to improve glycemic control in adults with type 2 d…
The FDA approved Segluromet, a combination of ertugliflozin and metformin, to improve blood sugar control in adults with type 2 diabetes. It…
FDA Approves Janumet XR (sitagliptin/metformin) for Type 2 Diabetes
FDA approves new once-daily combination pill Janumet XR for type 2 diabetes.
The FDA approved Janumet XR (sitagliptin and metformin HCl extended-release) as an adjunct to diet and exercise to improve glycemic control …
The FDA approved Janumet XR, a once-daily pill combining sitagliptin and metformin, to improve blood sugar control in adults with type 2 dia…